GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers.
GT Biopharma has a worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in San Francisco, CA.
GT Biopharma, Inc. is a clinical-stage immuno-oncology company, indicating a mid-stage growth phase. The company focuses on developing innovative therapies using its proprietary NK cell engager (TriKE®) technology. With a focus on targeting cancers like acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia, and multiple solid tumors, GT Biopharma is in the process of advancing its pipeline in the competitive biopharmaceutical sector.
GT Biopharma has achieved significant milestones in its history, notably the development of novel immuno-oncology biopharmaceutical drugs and the successful implementation of its TriKE® technology platform. The company has made strides in advancing therapeutic agents that facilitate the killing of cancer cells by leveraging NK cells and direct interaction with cancer cells. These milestones mark GT Biopharma's progress in developing targeted immunotherapies for various cancer indications, positioning it as a key player in the field of immuno-oncology.
GT Biopharma has been involved in notable case studies involving the development of immuno-oncology biopharmaceutical drugs targeting specific types of cancers. These case studies highlight the efficacy of TriKE® technology in facilitating the killing of cancer cells by engaging both NK cells and cancer cells. By showcasing the impact of its therapies on treating diseases like acute lymphocytic leukemia, non-Hodgkin's lymphoma, and acute myeloid leukemia, GT Biopharma demonstrates the potential of its innovative approaches in revolutionizing cancer treatment strategies.
In recent years, GT Biopharma has been actively involved in key events such as participating in the 3rd Annual ROTH Healthcare Opportunities Conference and hosting a virtual KOL event to showcase its NK cell engager pipeline. The company's presence at industry conferences, along with engagement with key opinion leaders, reflects its strategic approach to expanding its market reach and highlighting the potential of its immuno-oncology therapies. Furthermore, by providing investors with email alerts and updates, GT Biopharma aims to keep stakeholders informed about its progress and upcoming developments in the field of oncology.
-
Active
Health Care/Life Sciences
315 Montgomery Street 10th Floor San Francisco California 94104 United States...
United States
2
Rajesh C. Shrotriya (Independent Director)
Alan Louis Urban (Chief Financial Officer & Secretary)
Rajesh C. Shrotriya (Independent Director)
GTB-3550 TRIKE®
GTB-3650 TRIKE®
GTB-5550 TRIKE®
GTB-4550 TRIKE®
GTB-6550 TRIKE®
-
$3.12
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDCAiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
-
Health Care/Life Sciences
315 Montgomery Street 10th Floor San Francisco California 94104 United States...
United States
2+
-
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers.
GT Biopharma has a worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in San Francisco, CA.
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC